29.27
-0.09 (-0.31%)
| Penutupan Terdahulu | 29.36 |
| Buka | 29.50 |
| Jumlah Dagangan | 43,324 |
| Purata Dagangan (3B) | 1,695,296 |
| Modal Pasaran | 4,826,652,160 |
| Harga / Pendapatan (P/E TTM) | 13.94 |
| Harga / Pendapatan (P/E Ke hadapan) | 20.00 |
| Harga / Jualan (P/S) | 3.20 |
| Harga / Buku (P/B) | 3.15 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Jul 2025 |
| Margin Keuntungan | 23.30% |
| Margin Operasi (TTM) | 4.50% |
| EPS Cair (TTM) | 2.10 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -12.50% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -39.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 4.90% |
| Nisbah Semasa (MRQ) | 3.33 |
| Aliran Tunai Operasi (OCF TTM) | 516.83 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 429.53 M |
| Pulangan Atas Aset (ROA TTM) | 11.62% |
| Pulangan Atas Ekuiti (ROE TTM) | 25.71% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Alkermes plc | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -3.5 |
| Purata | 1.13 |
|
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.49% |
| % Dimiliki oleh Institusi | 106.94% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 46.00 (HC Wainwright & Co., 57.16%) | Pegang |
| Median | 42.50 (45.20%) | |
| Rendah | 40.00 (RBC Capital, 36.66%) | Pegang |
| Purata | 42.83 (46.33%) | |
| Jumlah | 4 Beli, 2 Pegang | |
| Harga Purata @ Panggilan | 30.12 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 21 Jul 2025 | 46.00 (57.16%) | Pegang | 29.27 |
| Needham | 21 Jul 2025 | 45.00 (53.74%) | Beli | 29.27 |
| 28 May 2025 | 45.00 (53.74%) | Beli | 29.90 | |
| Goldman Sachs | 15 Jul 2025 | 43.00 (46.91%) | Beli | 28.85 |
| UBS | 17 Jun 2025 | 42.00 (43.49%) | Beli | 29.77 |
| 28 Apr 2025 | 33.00 (12.74%) | Pegang | 27.91 | |
| Baird | 02 May 2025 | 41.00 (40.08%) | Beli | 31.78 |
| RBC Capital | 02 May 2025 | 40.00 (36.66%) | Pegang | 31.78 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 21 Jul 2025 | Pengumuman | Alkermes Announces Positive Topline Results From Vibrance-1 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1 |
| 15 Jul 2025 | Pengumuman | Alkermes to Report Second Quarter Financial Results on July 29, 2025 |
| 02 Jun 2025 | Pengumuman | Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences |
| 02 Jun 2025 | Pengumuman | Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference |
| 29 May 2025 | Pengumuman | Alkermes to Present New Research Related to ALKS 2680 at SLEEP 2025 |
| 01 May 2025 | Pengumuman | Alkermes plc Reports First Quarter 2025 Financial Results |
| 30 Apr 2025 | Pengumuman | New Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD) |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |